
While the P4 trial represents a landmark study on the use of CCTA guidance for percutaneous coronary intervention (PCI), there are pertinent caveats that warrant closer inspection.
Findings include hypodense hepatomegaly, ascites
Findings: Hypodense hepatomegaly, ascites






